Generated by AI
Nephros Inc. is a commercial-stage water technology company focused on filtration solutions for medical and commercial markets. Nephros develops and sells ultrafiltration products used in hospitals, dialysis centers, and other healthcare settings to help remove biological contaminants and support infection control. Its product portfolio also includes commercial water filters designed to improve water taste and odor while reducing biofilm, bacteria, cysts, particulates, and scale in downstream equipment. The company serves customers across healthcare, food service, hospitality, convenience retail, and other water-sensitive environments. Nephros also offers pathogen detection systems and water-quality education as part of its broader approach to water safety. Based in South Orange, New Jersey, Nephros operates with a strong emphasis on water purification, contamination reduction, and practical water-management applications in specialized markets.
Website380 Lackawanna Place
South Orange, NJ, 07079
United States
The latest articles about NEPH.
Nephros Inc (NEPH) posted 18% revenue growth and record active sites in Q3 2026, but gross margin slipped to 58% on tariffs, freight costs, and a shift toward lower-margin service revenue.
Tipranks Press Release.
Summary of Aug 13's posts. Generated by AI.
Summary of Aug 13's posts. Generated by AI.
No summary yet.
Summary of Aug 11's posts. Generated by AI.
Investors talking about NEPH also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.